Detalhe da pesquisa
1.
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.
Cell
; 173(6): 1413-1425.e14, 2018 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29754815
2.
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors.
Nat Cancer
; 4(2): 240-256, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36759733
3.
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities.
Nat Cell Biol
; 21(6): 778-790, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31160710
4.
PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma.
Mol Cancer Ther
; 17(4): 849-857, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29440296
5.
An ATG16L1-dependent pathway promotes plasma membrane repair and limits Listeria monocytogenes cell-to-cell spread.
Nat Microbiol
; 3(12): 1472-1485, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30478389
6.
Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.
Nat Commun
; 8: 15580, 2017 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-28561042
7.
FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 22(15): 3884-93, 2016 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26936917
8.
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling.
Oncotarget
; 7(25): 37407-37419, 2016 Jun 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27270648
9.
TGF-ß: an emerging player in drug resistance.
Cell Cycle
; 12(18): 2960-8, 2013 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23974105
10.
Drug therapy: Exploiting synthetic lethality to improve cancer therapy.
Nat Rev Clin Oncol
; 14(6): 331-332, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28352131
11.
Rapid temporal control of Foxp3 protein degradation by sirtuin-1.
PLoS One
; 6(4): e19047, 2011 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-21533107
12.
High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates.
AIDS
; 24(5): 669-73, 2010 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-19926962